0,944  0,005  Antiinflammatory
0,934  0,005  Apoptosis agonist
0,908  0,002  NOS2 expression inhibitor
0,908  0,004  Antileukemic
0,890  0,003  Cytostatic
0,858  0,005  Antineoplastic (breast cancer)
0,856  0,005  Antineoplastic (lung cancer)
0,845  0,004  Nitric oxide antagonist
0,833  0,005  Antineoplastic (colorectal cancer)
0,833  0,005  Antineoplastic (colon cancer)
0,824  0,004  Sensitization
0,799  0,004  Antineoplastic (glioma)
0,788  0,004  Cardiovascular analeptic
0,751  0,007  Chemopreventive
0,724  0,003  Antihelmintic
0,723  0,005  Antiparasitic
0,684  0,004  Antiseptic
0,671  0,005  Antineoplastic (glioblastoma multiforme)
0,677  0,023  Transcription factor NF kappa B inhibitor
0,652  0,007  Immunosuppressant
0,635  0,008  Antineoplastic (pancreatic cancer)
0,631  0,006  Antineoplastic (multiple myeloma)
0,583  0,017  Antineoplastic (ovarian cancer)
0,558  0,005  Antineoplastic (liver cancer)
0,559  0,018  Antipruritic, allergic
0,535  0,004  Antiviral (Influenza A)
0,546  0,025  Prostate cancer treatment
0,519  0,003  Expectorant
0,532  0,016  Antifungal
0,505  0,003  Aromatase inhibitor
0,511  0,018  Antineoplastic (brain cancer)
0,511  0,021  Antineoplastic (cervical cancer)
0,513  0,033  Antiprotozoal
0,515  0,036  Antibacterial
0,514  0,038  CYP3A4 substrate
0,487  0,014  ICAM1 expression inhibitor
0,464  0,005  Antiviral (Influenza)
0,457  0,005  Interleukin 6 antagonist
0,456  0,008  Contraceptive
0,444  0,003  Mucolytic
0,422  0,004  Antiprotozoal (Amoeba)
0,439  0,033  Antineoplastic (melanoma)
0,472  0,072  Caspase 9 stimulant
0,437  0,038  Respiratory analeptic
0,398  0,011  Prostate disorders treatment
0,405  0,020  Antineoplastic (endocrine cancer)
0,414  0,034  Cytotoxic
0,402  0,023  Antineoplastic (renal cancer)
0,385  0,012  Antipruritic, non-allergic
0,368  0,016  Platelet adhesion inhibitor
0,386  0,035  CYP3A4 inhibitor
0,359  0,015  Antiacne
0,370  0,037  Antiprotozoal (Leishmania)
0,348  0,014  Pneumotoxic
0,370  0,039  Antineoplastic (non-small cell lung cancer)
0,332  0,005  Opioid kappa receptor antagonist
0,332  0,006  Androgen antagonist
0,338  0,015  Antialcoholic
0,369  0,048  Apoptosis antagonist
0,333  0,016  Interferon gamma antagonist
0,363  0,047  Analeptic
0,336  0,028  Abortion inducer
0,340  0,040  Antineoplastic (lymphoma)
0,302  0,005  Antiprotozoal (Trichomonas)
0,315  0,021  Prostatic (benign) hyperplasia treatment
0,338  0,054  Teratogen
0,321  0,037  Antineoplastic (lymphocytic leukemia)
0,336  0,059  NOS3 expression inhibitor
0,281  0,024  Neurotrophic factor enhancer
0,312  0,057  Antioxidant
0,279  0,025  Antineoplastic (carcinoma)
0,260  0,008  Contraceptive female
0,293  0,046  DNA synthesis inhibitor
0,286  0,041  Sigma receptor agonist
0,253  0,010  Antieczematic
0,246  0,004  Opioid kappa receptor agonist
0,267  0,025  Cholinergic
0,311  0,070  Sodium/bile acid cotransporter inhibitor
0,314  0,074  AR expression inhibitor
0,296  0,060  Embryotoxic
0,265  0,039  Hepatoprotectant
0,332  0,110  TNF expression inhibitor
0,234  0,013  Microtubule formation inhibitor
0,260  0,041  VCAM1 expression inhibitor
0,304  0,088  Calcium channel activator
0,275  0,059  5 Hydroxytryptamine uptake stimulant
0,299  0,083  Hepatic disorders treatment
0,228  0,013  Arachidonic acid antagonist
0,254  0,040  UGT2B7 substrate
0,245  0,031  Antineoplastic (squamous cell carcinoma)
0,233  0,024  Acetylcholinesterase inhibitor
0,259  0,051  Mutagenic
0,235  0,030  Carcinogenic, group 3
0,269  0,065  Proliferative diseases treatment
0,229  0,032  Antipruritic
0,263  0,069  Tumour necrosis factor alpha release inhibitor
0,244  0,056  Carcinogenic
0,211  0,028  Antifungal enhancer
0,262  0,079  Transcription factor STAT inhibitor
0,225  0,043  Lipocortins synthesis antagonist
0,215  0,032  UGT2B9 substrate
0,186  0,004  Glycine receptor agonist
0,259  0,083  UGT2B4 substrate
0,178  0,005  Hypercalcemia treatment
0,253  0,081  Transcription factor STAT3 inhibitor
0,194  0,022  Antineoplastic antibiotic
0,178  0,008  Anabolic
0,270  0,102  Bone diseases treatment
0,274  0,108  Cholesterol antagonist
0,273  0,108  Antithrombotic
0,181  0,019  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,170  0,009  T cell inhibitor
0,202  0,041  Protein kinase stimulant
0,252  0,095  GST M1-1 substrate
0,198  0,042  Melanin inhibitor
0,239  0,083  Antipyretic
0,175  0,019  Opioid antagonist
0,156  0,006  Glycine receptor antagonist
0,196  0,046  Hair growth stimulant
0,150  0,015  Paget's disease treatment
0,182  0,053  UGT2B10 substrate
0,191  0,062  UGT1A4 substrate
0,132  0,011  Na+ K+ transporting ATPase inhibitor
0,146  0,028  Antiinfertility, female
0,159  0,042  Protein-tyrosine phosphatase 1B inhibitor
0,125  0,009  Androgen agonist
0,144  0,029  Antineoplastic alkaloid
0,125  0,011  Narcotic antagonist
0,174  0,060  Protein-tyrosine phosphatase inhibitor
0,150  0,039  Carcinogenic, group 2B
0,176  0,066  Toxic, respiratory center
0,137  0,030  Estrogen antagonist
0,110  0,004  Lipocortins synthesis agonist
0,106  0,009  5-Alpha-reductase inhibitor
0,149  0,054  Farnesoid X receptor antagonist
0,213  0,120  Cardioprotectant
0,156  0,063  Genotoxic
0,187  0,099  Antineoplastic enhancer
0,172  0,085  Antiviral (Hepatitis)
0,255  0,168  CYP2C19 inhibitor
0,094  0,008  Postcoital contraceptive
0,119  0,033  Estrogen receptor beta antagonist
0,204  0,119  Antineoplastic (sarcoma)
0,094  0,009  Progesterone antagonist
0,191  0,110  Antihypercholesterolemic
0,134  0,054  Cholesterol synthesis inhibitor
0,092  0,015  Opioid agonist
0,172  0,095  UGT1A1 substrate
0,199  0,127  Antiosteoporotic
0,104  0,034  Inducible nitric-oxide synthase inhibitor
0,112  0,043  UGT2B11 substrate
0,164  0,096  Antirickettsial
0,171  0,103  Antimitotic
0,140  0,073  Ca2+-transporting ATPase inhibitor
0,070  0,007  Parathyroid hormone antagonist
0,094  0,031  CDC25A inhibitor
0,074  0,013  Mineralocorticoid receptor antagonist
0,142  0,082  Antidiarrheal
0,068  0,009  Glucocorticoid antagonist
0,102  0,044  Bile acid receptor antagonist
0,184  0,126  RNA-directed DNA polymerase inhibitor
0,222  0,164  GST A substrate
0,139  0,083  Adenylate cyclase stimulant
0,059  0,004  Progesterone agonist
0,070  0,016  Estrogen receptor beta agonist
0,091  0,039  Antibiotic
0,131  0,079  Neurotrophic factor
0,097  0,050  Actinic keratosis treatment
0,085  0,038  Opioid mu receptor antagonist
0,051  0,004  Vitamin D receptor antagonist
0,180  0,134  DNA damaging
0,130  0,085  UGT2B15 substrate
0,052  0,007  Tubulin agonist
0,047  0,003  Progesterone receptor B antagonist
0,117  0,073  Growth stimulant
0,092  0,049  Transcription factor NF kappa B stimulant
0,094  0,051  Ornithine decarboxylase inhibitor
0,142  0,101  Antiviral (Hepatitis C)
0,058  0,018  Microtubule stabilization
0,094  0,055  Thioredoxin inhibitor
0,089  0,051  Antispirochetal
0,127  0,090  Acaricide
0,147  0,110  Diabetic nephropathy treatment
0,064  0,028  Protein 50S ribosomal subunit inhibitor
0,144  0,108  Tumour necrosis factor antagonist
0,130  0,098  Pregnane X receptor agonist
0,061  0,030  Estrogen agonist
0,072  0,041  SULT2A1 substrate
0,146  0,117  UDP-glucuronosyltransferase substrate
0,078  0,050  Analgesic, opioid
0,033  0,005  Corticosteroid-like
0,069  0,042  Glutamate (mGluR6) antagonist
0,042  0,016  RNA-directed RNA polymerase stimulant
0,052  0,027  Aldosterone antagonist
0,127  0,103  Eye irritation, high
0,070  0,047  Anticholelithogenic
0,077  0,054  Estrogen receptor alpha antagonist
0,054  0,031  Anesthetic inhalation
0,026  0,006  Glucocorticoid agonist
0,086  0,066  Contraceptive male
0,197  0,178  CTGF expression inhibitor
0,126  0,109  Antifungal (Cryptococcus)
0,194  0,178  Caspase 3 stimulant
0,060  0,046  Antimycoplasmal
0,026  0,013  CYP24 inhibitor
0,047  0,034  Cholesterol esterase inhibitor
0,075  0,062  Chymotrypsin inhibitor
0,192  0,180  Antihypertensive
0,084  0,074  SULT1E1 substrate
0,015  0,004  Progesterone receptor A antagonist
0,140  0,129  Angiogenesis stimulant
0,137  0,128  Psychostimulant
0,071  0,063  Keratolytic
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,113  0,106  Vanilloid 1 agonist
0,090  0,087  UGT2B1 substrate
0,134  0,133  Anesthetic general

